The Mercom Capital regular report on health care information technology financings and transactions shows that over $850 million was invested in the first quarter of 2014.
iKang Healthcare Group has gone public on NASDAQ, which seems a little unusual only because the company operates clinics in China. The company raised over $100 million to continue expansion.
According to Rock Health, $700 million was invested in mhealth companies, broadly defined, in the first three months of 2014, up sharply from the same period last year.
Omada, which says it is in the business of "digital therapeutics" (I am not laughing) has raised $23 million (now I am) for its software and apps (what else could it be) that will help patients with chronic illnesses achieve better outcomes.
Sheridan Healthcare, a physician staffing company in areas like radiology and anesthesiology, apparently intends to file for an initial public offering.
Wellframe, which intends to help people be "engaged in personalized care plans" has raised a $1.5 million seed round. Gag me if I hear about one more mobile health app to help consumers.
In a complicated transaction that appears to relieve some of the burden of supporting its financially struggling company-based clinic business, Walgreens has sold a majority interest in its TakeCare clinics to private equity firm Water Street, while Water Street was also buying a majority interest in the CHS employer worksite clinic business. Water Street intends to merge the two entities, which will have about 500 clinics.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.